Various international guidelines have suggested that HCC surveillance should be done every 3 to 4 months for the first year, and then every 6 months for 3 years, by CT or MRI, along with AFP monitoring [11, 45, 46]. This evidence concerns the gene AFP and hepatocellular carcinoma.